Connor, Clark & Lunn Investment Management Ltd. Bio Rad Laboratories, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $453,436 - $619,022	1,099 Added 68.26%	2,709 $1.13 Million
Q2 2022 Aug 05, 2022	BUY	$463.67 - $597.16 $746,508 - $961,427	1,610 New	1,610 $797,000
Q1 2022 May 12, 2022	SELL	$524.57 - $735.42 $1.34 Million - $1.88 Million	-2,562 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $1.03 Million - $1.16 Million	-1,455 Reduced 36.22%	2,562 $1.94 Million
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $2.64 Million - $3.32 Million	4,017 New	4,017 $3 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $4.98 Million - $5.61 Million	-8,637 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $1.5 Million - $1.81 Million	-2,734 Reduced 24.04%	8,637 $4.93 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $2.26 Million - $2.85 Million	-4,423 Reduced 28.0%	11,371 $6.63 Million
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $1.67 Million - $1.96 Million	3,664 Added 30.21%	15,794 $8.14 Million
Q2 2020 Aug 13, 2020	SELL	$334.87 - $493.06 $3.22 Million - $4.74 Million	-9,620 Reduced 44.23%	12,130 $5.48 Million
Q1 2020 May 13, 2020	SELL	$320.01 - $409.07 $24,000 - $30,680	-75 Reduced 0.34%	21,750 $7.62 Million
Q4 2019 Feb 12, 2020	BUY	$319.73 - $374.2 $3.64 Million - $4.27 Million	11,400 Added 109.35%	21,825 $8.08 Million
Q3 2019 Nov 13, 2019	BUY	$304.55 - $345.24 $1.67 Million - $1.89 Million	5,475 Added 110.61%	10,425 $3.47 Million
Q2 2019 Aug 07, 2019	BUY	$286.93 - $312.59 $1.42 Million - $1.55 Million	4,950 New	4,950 $1.55 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account